TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
Titel:
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
Auteur:
Loriot, Y. Petrylak, D.P. Rezazadeh Kalebasty, A. Fléchon, A. Jain, R.K. Gupta, S. Bupathi, M. Beuzeboc, P. Palmbos, P. Balar, A.V. Kyriakopoulos, C.E. Pouessel, D. Sternberg, C.N. Tonelli, J. Sierecki, M. Zhou, H. Grivas, P. Barthélémy, P. Tagawa, S.T.